November 8, 2019

Odan Laboratories is pleased to announce the availability of ODAN LEVOCARNITINE.

This medication is indicated for the treatment of primary systemic carnitine deficiency and acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency.

Available in oral solution in 118 mL.